The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
about
Patient-identified disease burden in facioscapulohumeral muscular dystrophy.Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial.Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trialFatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe diseaseDetermining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol.Effectiveness and cost-effectiveness of a self-management group program to improve social participation in patients with neuromuscular disease and chronic fatigue: protocol of the Energetic study.Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.Sarcolemma-localized nNOS is required to maintain activity after mild exercisePatient identification of the symptomatic impact of charcot-marie-tooth disease type 1A.184th ENMC International Workshop: pain and fatigue in neuromuscular disorders: 20-22 May 2011, Naarden, The Netherlands.Measuring Habitual Physical Activity in Neuromuscular Disorders: A Systematic Review.A systematic review of quality of life in adults with muscle disease.What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.Fatigue in facioscapulohumeral muscular dystrophy: a qualitative study of people's experiences.A study of physical activity comparing people with Charcot-Marie-Tooth disease to normal control subjects.Fatigue leads to gait changes in spinal muscular atrophy.Systemic AAV-Mediated β-Sarcoglycan Delivery Targeting Cardiac and Skeletal Muscle Ameliorates Histological and Functional Deficits in LGMD2E Mice.How persons with a neuromuscular disease perceive employment participation: a qualitative study.It's more than just physical therapy: reported utilization of physiotherapy services for adults with neuromuscular disorders attending a specialist centre.Severe fatigue after kidney transplantation: a highly prevalent, disabling and multifactorial symptom.Severe fatigue and reduced quality of life in children with hereditary motor and sensory neuropathy 1A.Neuromuscular function after muscle fatigue in Charcot-Marie-Tooth type 1A patients.Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.No Reduction of Severe Fatigue in Patients With Postpolio Syndrome by Exercise Therapy or Cognitive Behavioral Therapy: Results of an RCT.Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.Severe fatigue in narcolepsy with cataplexy.Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis.Role of disease severity, illness perceptions, and mood on quality of life in muscle disease.Functioning and disability in adults with myotonic dystrophy type 1.
P2860
Q30583657-7E47F236-9505-4DF6-9BB5-AAAABC5BA470Q33524909-3EFBFFC3-BB57-4896-9783-AD607157E567Q33621897-75930BA8-C2C4-474F-98B8-01FB17CE9E72Q33666033-0CB92D24-05D9-4A1F-A53D-0713C15DAFD0Q35015983-360BF6FA-10F4-4D73-943A-673277C3E1BCQ35544490-8D99A055-330F-43D4-9688-A58A4C838924Q35668084-46562AC2-B7AA-4393-A8CB-1BCF8A7B835BQ36576057-B4CA8F07-3D9C-45A8-B09A-1CE814354294Q36987100-9280A87F-02B0-4699-9351-A3DD9D63AF87Q37119243-9E235C47-5A33-48F7-9549-093B6116004AQ37426701-DC6CC146-071C-4A62-82EE-432FC38CECDBQ37693358-5E08999E-6BA7-4F0D-90E6-1AB105AC5037Q37877603-A9A01001-CB2A-429E-851E-2E46082F0557Q38728144-35988199-A4D7-413C-9E92-CD227C528A6BQ39267660-DE402511-99C2-414A-9EA3-417E0BF2C739Q39340131-65C5A94B-9231-4680-B16F-52D26CC66321Q39771805-63F4B5D7-7A05-4265-809F-4CA98FCBC009Q40296355-BCB5B331-2B0D-475C-A31A-04B587441697Q42597956-6FCE0580-D9D7-42D1-8D38-B0794F2ABECFQ42652806-4823CDAE-E183-44DA-8CA2-3BD32F10E062Q46129524-6D1F73E1-E6B9-423D-AC7E-CD0311FFD1C9Q46980688-E56186E5-27A7-4417-9779-83C3B41D88CCQ47242046-977D1856-0ECF-437B-B536-8E05E9A3D024Q47691178-01ED2C4B-CED9-4FBB-843B-9D1131862740Q47992803-7C3DE9ED-8B5A-46C0-B653-0C8378277F7DQ48265187-BBF14E12-00EC-4DEB-AE2C-C112D11D2973Q48287879-92894295-6CD7-42FD-8165-E2D2DC89705DQ48364560-0D9BAB2F-C1D3-44BA-933C-2AA6A33DF0CEQ48398946-76888182-E038-4938-8B7F-43039233918CQ48705620-7466331B-D961-4A82-8265-CCCB208B5324
P2860
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@en
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@nl
type
label
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@en
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@nl
prefLabel
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@en
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@nl
P2093
P1476
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
@en
P2093
Baziel G M van Engelen
Gijs Bleijenberg
Joke S Kalkman
Maartje L Schillings
Machiel J Zwarts
P304
P356
10.1016/J.JPSYCHORES.2006.11.014
P577
2007-05-01T00:00:00Z